Sanofi Share Price Today
(NASDAQ: SNY)

Name: Sanofi Share Price Today (NASDAQ: SNY) - Sanofi Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sanofi share price is $54.32 & ₹4,706.28 as on 1 Feb 2025, 2.30 'hrs' IST

$54.32

▲

0.17

(0.31%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Sanofi share price in Dollar and Rupees. Guide to invest in Sanofi stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sanofi, along with analyst recommendations, forecasts, and comprehensive financials.

Sanofi share price movements

Today's Low: $53.82
Today's High: $54.32
$54.32
0.93%
Downside
Day's Volatility :0.93%
Upside
0.0%
52 Weeks Low: $45.22
52 Weeks High: $58.97
$54.32
16.75%
Downside
52 Weeks Volatility :23.32%
Upside
7.89%

Sanofi (SNY) Returns

Period	Sanofi	Sector (Health Care)	Index (Russel 2000)
3 Months	2.27%	0.3%	0.0%
6 Months	5.25%	-1.5%	0.0%
1 Year	14.65%	5.0%	0.0%
3 Years	3.06%	12.3%	-12.8%

Sanofi (SNY) Key Statistics

in dollars & INR

Previous Close	$54.15
Open	$54.16
Today's High	$54.34
Today's Low	$53.815
Market Capitalization	$133.2B
Today's Volume	$4.7M
52 Week High	$58.97
52 Week Low	$45.22
Revenue TTM	$48.4B
EBITDA	$12.5B
Earnings Per Share (EPS)	$1.87
PE Ratio	27.89
Dividend Yield	3.91%
Profit Margin	9.3%
Quarterly Earnings Growth YOY	0.12%
Return On Equity TTM	5.82%

How to invest in Sanofi Stock (SNY) from India?

It is very easy for Indian residents to invest directly in Sanofi from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sanofi stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sanofi or SNY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sanofi or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sanofi shares which would translate to 0.016 fractional shares of Sanofi as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sanofi, in just a few clicks!

Returns in Sanofi (SNY) for Indian investors in Rupees

The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sanofi investment value today

Current value as on today

₹1,16,627

Returns

₹16,627

(+16.63%)

Returns from Sanofi Stock

₹12,208 (+12.21%)

Dollar Returns

₹4,419 (+4.42%)

Indian investors sentiment towards Sanofi (SNY)

-29%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Sanofi Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sanofi

Dodge & Cox
3.04%
Morgan Stanley - Brokerage Accounts
0.71%
Fisher Asset Management, LLC
0.53%
Amvescap Plc.
0.46%
Bank of America Corp
0.46%
BlackRock Inc
0.41%

Analyst Recommendation on Sanofi

Buy

74%Buy

22%Hold

3%Sell

Based on 31 Wall street analysts offering stock ratings for Sanofi(by analysts ranked 0 to 5 stars)

Based on 31 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sanofi Stock (SNY)

What analysts predicted

Upside of 15.31%

Target:

$62.63

Current:

$54.32

Insights on Sanofi Stock (Ticker Symbol: SNY)

Price Movement
In the last 7 days, SNY stock has moved up by 3.2%
Increasing Revenue
Sanofi has shown positive revenue growth over the past three quarters, increasing from $11.11 billion to $14.15 billion. This reflects an average quarterly growth rate of 11.0%.
Increasing Net Profit
Sanofi has shown strong profit growth over the last two quarters. Their net profit increased from $1.11 billion to $2.81 billion, representing an average increase of 60.5% per quarter.
SNY vs LLY (1 yr)
In the last 1 year, Eli Lilly And Company has given 27.5% return, outperforming this stock by 19.0%
SNY vs LLY (3 yr)
In the last 3 years, Eli Lilly And Company has given 235.5% return, outperforming this stock by 231.4%
Price to Sales
Sanofi has a Price-to-Sales Ratio of 2.8, meaning investors are willing to pay $2.8 for every $1 of sales generated by the company. In comparison, Eli Lilly And Company has a significantly higher Price-to-Sales Ratio of 18.1, indicating that investors are paying much more per dollar of sales for Eli Lilly than for Sanofi.

Sanofi Technicals Summary

Sell

Neutral

Buy

Sanofi is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sanofi (SNY) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sanofi	12.37%	5.25%	14.65%	3.06%	11.93%
Eli Lilly And Company	5.8%	6.19%	23.3%	228.2%	483.85%
Johnson & Johnson	6.14%	-5.2%	-2.39%	-11.52%	1.8%
Merck & Co. Inc.	-0.22%	-11.9%	-21.72%	20.66%	13.29%
Novo Nordisk A/s	-2.49%	-32.27%	-24.94%	60.13%	179.99%
Abbvie Inc	-2.11%	-4.72%	4.14%	26.71%	113.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sanofi	27.89	27.89	0.96	3.97	0.06	0.04	0.04	58.1
Eli Lilly And Company	89.0	89.0	0.76	12.89	0.65	0.14	0.01	15.83
Johnson & Johnson	26.11	26.11	0.96	10.55	0.21	0.08	0.03	29.14
Merck & Co. Inc.	20.56	20.56	0.07	7.65	0.28	0.11	0.03	17.58
Novo Nordisk A/s	28.29	28.29	1.4	22.15	0.89	0.21	0.02	27.07
Abbvie Inc	61.07	61.07	0.41	10.45	0.56	0.08	0.04	3.41

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sanofi	Buy	$133.2B	11.93%	27.89	9.3%
Eli Lilly And Company	Buy	$740.3B	483.85%	89.0	20.48%
Johnson & Johnson	Buy	$363.9B	1.8%	26.11	16.74%
Merck & Co. Inc.	Buy	$248.6B	13.29%	20.56	19.23%
Novo Nordisk A/s	Buy	$379.5B	179.99%	28.29	35.01%
Abbvie Inc	Buy	$309.7B	113.43%	61.07	9.22%

Sanofi Dividend announcements

Sanofi Dividends June, 2024
In the quarter ending June,2024. Sanofi has declared dividend of $2.04
Read More

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Organization	Sanofi
Employees	86088
CEO	Mr. Paul Hudson
Industry	Health Technology

Management People of Sanofi

Name	Title
Mr. Paul Hudson	CEO & Director
Mr. François-Xavier Roger	Executive VP & CFO
Ms. Madeleine Roach	Executive VP & Head of Business Operations
Mr. Laurent Gilhodes	Principal Accounting Officer and Vice President of Corporate Accounting
Dr. Josephine Fubara	Chief Science Officer of Consumer Health Care
Mr. Thomas Kudsk Larsen	Head of Investor Relations
Mr. Dante Beccaria	Global Compliance Officer & VP
Mr. Roy Papatheodorou	Executive VP & General Counsel
Mr. Josep Catlla	Head of Communications
Mr. Pierre Chancel	Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing

Important FAQs about investing in SNY Stock from India :

What is Sanofi share price today?

Sanofi share price today stands at $54.32, Open: $53.82 ; Previous Close: $54.15 ; High: $54.32 ; Low: $53.82 ; 52 Week High: $58.97 ; 52 Week Low: $45.22.

The stock opens at $53.82, after a previous close of $54.15. The stock reached a daily high of $54.32 and a low of $53.82, with a 52-week high of $58.97 and a 52-week low of $45.22.

Can Indians buy Sanofi shares?

Yes, Indians can invest in the Sanofi (SNY) from India.

With INDmoney, you can buy Sanofi at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sanofi at zero transaction cost.

How can I buy Sanofi shares from India?

It is very easy to buy Sanofi from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sanofi (SNY) be purchased?

Yes, you can buy fractional shares of Sanofi with INDmoney app.

What are the documents required to start investing in Sanofi stocks?

To start investing in Sanofi, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.